Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.19.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2019
Mar. 31, 2019
Current assets    
Cash $ 785,658 $ 3,828,074
Prepaid expenses and other current assets 114,036 210,042
Total current assets 899,694 4,038,116
Property and equipment, net 124,833 6,021
Right-of-use lease asset 183,018 0
Patents, net 62,086 66,668
Deposits 12,159 12,159
Total assets 1,281,790 4,122,964
Current liabilities    
Accounts payable 586,960 131,931
Due to related parties 101,462 83,654
Convertible notes payable, net 0 962,301
Deferred revenue 100,000 0
Lease liability, current portion 94,885 0
Other current liabilities 285,211 646,000
Total current liabilities 1,168,518 1,823,886
Lease liability, less current portion 92,600 0
Total liabilities 1,261,118 1,823,886
Commitments and Contingencies (Note 13)
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 1,337,259 and 1,266,979 shares issued and outstanding as of September 30, 2019 and March 31, 2019, respectively 1,338 1,267
Additional paid-in capital 109,571,708 108,076,275
Accumulated deficit (109,423,894) (105,652,433)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 149,152 2,425,109
Noncontrolling interests (128,480) (126,031)
Total stockholders' equity 20,672 2,299,078
Total liabilities and stockholders' equity $ 1,281,790 $ 4,122,964